dFDA LogoFDA.gov v2

Clinical Trials for Type 2 Diabetes

Focusing on: GLP-1 Receptor Agonists

Specify a medical condition you are interested in.

Specify a drug, device, or procedure if you are looking for trials for a specific intervention.

Displaying 10 of 778 results.

Page 1 of 78

Effect of GLP-1 Receptor Agonists on Trabecular Bone Score

Terminated
Study Type:
INTERVENTIONAL
Phase:
PHASE2
Enrollment: 5
Age: From 55 Years
Gender: FEMALE
Locations: University of Mississippi Medical Center
Last Updated: N/A
Has Results
View Study Details

Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM

Completed
Study Type:
INTERVENTIONAL
Phase:
NA
Enrollment: 338
Age: 25 Years - 70 Years
Gender: ALL
Locations: Department of Endocrinology
Last Updated: N/A
View Study Details

SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.

Completed
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 140
Age: From 18 Years
Gender: ALL
Locations: Centro de Salud de Culleredo; Centro de Salud de Fene; +9 more
Last Updated: N/A
View Study Details

Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients

Unknown Status
Last Known: RECRUITING
Study Type:
INTERVENTIONAL
Phase:
PHASE4
Enrollment: 315
Age: 21 Years - 75 Years
Gender: ALL
Locations: Dasman Diabetes Institute
Last Updated: N/A
Join Study

Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

Completed
Conditions:Type 2 Diabetes
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 10000
Age: 18 Years - 90 Years
Gender: ALL
Locations: Division of Metabolic Diseases, University Hospital of Padova
Last Updated: N/A
View Study Details

Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin

Unknown Status
Last Known: ACTIVE_NOT_RECRUITING
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 20000
Age: From 18 Years
Gender: ALL
Locations: Brigham and Women's Hospital
Last Updated: N/A
View Study Details

Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease

Completed
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 348
Age: From 18 Years
Gender: ALL
Locations: LMC Diabetes & Endocrinology Ltd.
Last Updated: N/A
View Study Details

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Unknown Status
Last Known: RECRUITING
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 20
Age: From 18 Years
Gender: ALL
Locations: Guy's and St Thomas' NHS Foundation Trust
Last Updated: N/A
Join Study

Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF

Completed
Study Type:
INTERVENTIONAL
Phase:
NA
Enrollment: 174
Age: From 18 Years
Gender: ALL
Locations: Shanghai Chest Hospital
Last Updated: N/A
View Study Details

Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

Completed
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 130
Age: From 50 Years
Gender: ALL
Locations: Azienda Ospedaliero-Universitaria Policlinico Bari
Last Updated: N/A
View Study Details